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ABSTRACT
Objectives To assess the influence of muscle power 
and adiposity on all- cause mortality risk and to evaluate 
the ’fat but powerful’ (F+P) (or ’fat but fit’) paradox in 
older adults.
Methods A total of 2563 older adults (65‒91 years 
old) from the EXERNET multicentre study were included. 
Adiposity (body mass index (BMI), waist circumference, 
body fat percentage (BF%) and fat index), allometric 
and relative power (sit- to- stand muscle power test) 
and various covariates (age, sex, hypertension, smoking 
status and walking and sitting times per day) were 
registered at baseline. All- cause mortality was recorded 
during a median follow- up of 8.9 years. Participants 
were classified into four groups: lean and powerful 
(L+P), F+P, lean but weak and fat and weak (F+W). Cox 
proportional hazard regression models and adjusted HRs 
were calculated.
Results According to BMI and waist circumference, 
all- cause mortality risk was reduced in the F+P 
(HR=0.55 and 0.63, p=0.044 and 0.049, respectively) 
and L+P (HR=0.57 and 0.58, p=0.043 and 0.025, 
respectively) groups. According to BF%, all- cause 
mortality decreased in the L+P group (HR=0.53; 
p=0.021), and a trend for a reduction was reported in 
the F+P group (HR=0.57; p=0.060). According to fat 
index, a survival benefit was only noted in the L+P group 
(HR=0.50; p=0.049). Higher levels of relative power 
reduced all- cause mortality risk among older people 
(HR=0.63 and 0.53, p=0.006 and 0.011, respectively).
Conclusion Powerful older people exhibited a reduced 
9- year all- cause mortality regardless of BMI, waist 
circumference and BF%. Obesity according to fat index 
blunted the survival benefits of being powerful.
INTRODUCTION
Physical fitness has been identified as one of the most 
important predictors of all- cause mortality among 
adults. Specifically, low cardiorespiratory fitness has 
been shown to be responsible for a greater number 
of deaths than other risk factors such as hyperten-
sion, smoking or metabolic disease.1 2 The relevance 
of achieving an adequate physical fitness status is 
such that people with obesity or metabolic disease 
who present adequate cardiorespiratory fitness 
exhibit a diminished mortality risk when compared 
with people without obesity or metabolic disease 
but presenting low cardiorespiratory fitness.3 This 
has been described as the ‘fat but fit’ paradox.4
The ‘fat but fit’ paradox has also been confirmed 
in older adults. Sui et al5 demonstrated that main-
taining an adequate cardiorespiratory fitness at older 
age decreases all- cause mortality risk independently 
of overall or abdominal adiposity. However, the 
assessment of cardiorespiratory fitness can demand 
considerable time and resources from the practi-
tioners and requires an effort until exhaustion from 
the older participants, which may limit its routine 
application in the clinical setting. Among the other 
components of physical fitness, muscle power (ie, 
product of force and velocity) has been found to be 
more strongly related with older adults’ functional 
status than cardiorespiratory capacity.6 Muscle 
power has also been reported to predict all- cause 
mortality among men, independently of physical 
activity, muscle mass and strength.7 Fortunately, 
muscle power can be assessed using a feasible proce-
dure that only requires a chair and a stopwatch and 
a few seconds to be conducted: the sit- to- stand 
(STS) muscle power test.8 9 Nevertheless, no studies 
have previously assessed the ‘fat but fit’ paradox 
while considering muscle power as the physical 
fitness component, which might be of special rele-
vance in older populations. Hence, the main goals 
of the present investigation were twofold: (1) to 
evaluate and compare all- cause mortality risk in 
a representative sample of non- institutionalised 
Spanish older adults presenting different combi-
nations of adiposity and muscle power and (2) to 
determine whether the ‘fat but fit’ paradox occurs 
when muscle power is regarded.
METHODS
Study design
This is a prospective study conducted in the 
participants of the EXERNET multicentre study 
(for further details, see Gomez- Cabello et al and 
Pedrero- Chamizo et al10 11). This study includes a 
representative sample of noninstitutionalised older 
adults (≥65 years old) living in Spain. Data were 
collected from June 2008 to November 2009 by 
means of personal interviews and physical exam-
ination (body composition and physical fitness). 
All the participants gave their written informed 
consent. The study was approved by the Clinical 
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and the Ethical Committee of the University Hospital Fundación 
Alcorcón (50/2016), and the procedures were performed in 
accordance with the Helsinki Declaration.
Participants
A total of 2563 older adults (602 older men and 1961 older 
women; all Caucasian) were included in this study. Inclusion 
criteria were age ≥65 years and independent living. Older people 
with dementia, cancer or terminal illness were excluded. Base-
line information of the study participants is shown in table 1.
Anthropometrics and body composition
Subjects remained in the standing position without shoes and 
shocks while using light clothing. Any metal object was removed. 
Height and body mass were assessed with a portable stadiom-
eter and scale device (SECA 225, SECA, Germany), and body 
mass index (BMI; kg·m−2) was calculated as the ratio between 
body mass and height squared. Waist circumference (cm) was 
measured at the narrowest point between the lower border of 
the last rib and the iliac crest with an inelastic measuring tape 
(Rosscraft Innovations, Canada). Whole body fat was estimated 
using a bioelectrical impedance analyzer (Tanita BC-418 MA, 
Tanita, Japan). Body fat percentage (%) was calculated as the 
ratio between body fat and body mass. Fat index (kg/m2) was 
calculated as the ratio between body fat and height squared. 
Then, obesity was identified separately in men and women for 
the different adiposity indexes: BMI ≥30 kg/m2 in both men and 
women12; waist circumference ≥101 cm in men and ≥88 cm 
in women13; body fat percentage ≥31% in men and ≥43% in 
women14 and fat index ≥9.05 kg/m2 in men and ≥13.06 kg/m2 
in women (highest sex- specific quintiles).
Muscle power
Muscle power was evaluated with the 30 s STS muscle power 
test.9 This test consists of performing as many STS repetitions 
as possible within 30 s on a standardised armless chair. Then, 
muscle power is calculated by means of a validated equation that 
considers the participant’s body mass and height, chair height 
(0.43 m) and 30 s STS performance. Strong verbal encourage-
ment was given to all the participants throughout the test. Abso-
lute muscle power values were normalised to height squared 
(i.e. allometric musle power) due to absolute muscle power is 
positively associated with height (r=0.48 in men and 0.47 in 
women).15 Low allometric power was identified in men with 
values <75.4 W/m2 and in women with values <61.5 W/m2 
(lowest sex- specific quintile), while values equal to or greater 
than these cut- off points were considered normal. In addition, 
relative muscle power (W/kg1) is a measure of muscle power that 
integrates information on physical fitness and adiposity levels 
since it can be calculated as allometric muscle power normalised 
to BMI. Of note, relative muscle power can also be obtained 
from the ratio between absolute muscle power and body mass. 
Low relative power was defined as showing values <2.6 W/kg1 
in men and <2.1 W/kg1 in women (lowest sex- specific quin-
tile), otherwise relative muscle power was considered normal. In 
addition, high relative power was identified in men with values 
≥4.0 W/kg1 and in women with values ≥3.2 W/kg1 (highest sex- 
specific quintile).
Covariates
Based on the evidence regarding mortality attributable to 
selected major risks, hypertension, smoking status, and physical 
activity and inactivity were registered.16 Resting systolic blood 
pressure was assessed with the participants in the sitting posi-
tion and after 10 min of rest. The average of two measurements 
separated by 2 min was obtained for further analysis. Hyperten-
sion was considered in participants with systolic blood pressure 
≥140 mm Hg. Smoking status, walking time and sedentary time 
were self- reported by the participants during the personal inter-
views through a validated questionnaire.17 Subjects were catego-
rised into two groups of smoking status (yes and no), two groups 
of physical activity (walking ≥1 hour and <1 hour/day; based on 
the highest quintile) and two groups of sedentary time (sitting 
≥5 hour and <5 hour/day, based on the highest quintile).
Survival data
All- cause mortality was collected in the study participants 
consulting the Spanish National Death Index during a median 
follow- up of 8.9 years (IQR=8.5‒9.1 years) that elapsed from 
the date of interview to the date of death or censoring (31 March 
2018).
Statistical analyses
Data were presented as mean±SD for continuous variables 
and as frequency and percentage for categorical variables. All 
continuous variables presented skewness values ranging between 
−0.46 and 0.62 and kurtosis values ranging between −0.18 
and 1.11, and so they were treated as normally distributed vari-
ables. Differences between deceased and surviving participants 
were assessed separately in men and women using unpaired 
t- tests for continuous variables (homogeneity of variances was 
assessed by Levene’s test) and χ2 tests for categorical variables 
(Fisher’s exact test was applied when expected counts were <5). 
To assess the ‘fat but powerful’ (F+P) paradox, four mutually 
exclusive groups were created for each adiposity variable: (1) 
lean and powerful (L+P) (nonobese people with normal allo-
metric power), (2)F+P (obese people with normal allometric 
power), (3) lean but weak (L+W) (nonobese people with low 
allometric power) and (4) fat and weak (F+W) (obese people 
with low allometric power). Finally, HRs and 95% CIs of all- 
cause mortality for each corresponding group of adiposity and 
allometric power (reference: F+W group) were calculated using 
Cox proportional hazards regression models, with time- on- study 
since data collection (months) as the time- scale, adjusted for age, 
sex (reference: men), hypertension, smoking status, walking 
Table 1 Baseline characteristics of the study participants
Men (n=602) Women (n=1961)
Mean±SD Mean±SD
Age (years) 72.1±5.4 72.0±5.2
Body mass (kg) 77.6±11.0 68.9±10.7
Height (m) 1.65±0.07 1.53±0.06
BMI (kg·m−2) 28.3±3.5 29.5±4.3
Waist circumference (cm) 99.2±10.0 93.0±12.3
Body fat (%) 29.1±5.1 39.7±5.2
Fat index (kg·m−2) 8.3±2.2 11.9±3.1
STS performance (reps) 15.0±3.6 14.1±3.3
Allometric power (W·m−2) 99.8±26.0 80.8±20.4
Relative power (W·kg−1) 3.54±0.83 2.76±0.67
Hypertension (yes, n(%)) 317(52.6) 984(50.2)
Smoking (yes, n(%)) 54(9.0) 33(1.7)
Walking <1 hour·day−1 (yes, n(%)) 170(28.2) 696(35.5)
Sitting ≥5 hour·day−1 (yes, n(%)) 110(18.3) 284(14.5)
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<1 hour/day and sitting ≥5 hour/day (all reference: no)). A 
directed acyclic graph is presented in figure 1 to illustrate the 
relation between the group of confounders and the exposure and 
outcome variables. Deaths within the first 2 years were excluded 
to minimise bias from reverse causation.18 The proportional 
hazard assumption was evaluated and confirmed by examination 
of the Kaplan- Meier curves showing survival probability over 
time. The linearity assumption was evaluated and confirmed 
by plotting Martingale residuals (y- axis) against age (x- axis). In 
addition, HR and 95% CI of all- cause mortality for each group 
of relative muscle power, as well as for relative muscle power 
introduced as a continuous variable, were obtained adjusting 
for the same covariates. The statistical power (1−β) of each 
comparison between the reference group and each of the other 
groups was analysed according to the procedures reported else-
where for survival analyses.19 The parameters considered were 
α (two- tailed)=0.05; q1 (proportion of subjects in the reference 
group); q0 (proportion of subjects in the other group); relative 
hazard (between the reference group and each of the other 
groups) and the total number of events recorded in the groups 
being compared.19 Statistical power values ranged between 
0.87 and 0.97 regardless of the adiposity marker used to assess 
the ‘F+P’ phenotype, except for the comparisons between the 
F+W (reference) and L+W group, that showed statistical power 
values ranging from 0.18 to 0.62. All statistical analyses were 
performed using SPSS V.20 (SPSS, USA) and the level of signifi-
cance was set at α=0.05.
RESULTS
A total of 241 older subjects (56 older men and 185 older 
women) were excluded due to loss to follow- up. The excluded 
participants were younger (70.8 vs 72.2 years old; p<0.001), 
had greater waist circumference (96.1 vs 94.3 cm; p=0.003) and 
allometric (89.0 vs 84.2 W/m2; p<0.001) and relative (3.0 vs 
2.9 W/kg1; p=0.005) muscle power levels and were less likely 
to have hypertension (41.4 vs 52.0%; p<0.001) compared 
with the participants that completed the follow- up period 
(median=8.9 years; IQR=8.5‒9.1 years). No differences were 
reported regarding sex, physical performance, smoking, physical 
activity behaviour and the other measures of body composition 
(all p>0.05).
Comparison between deceased and surviving older people
Of the participants that completed the 9- year follow- up, a total 
of 215 (9.3%) participants died (86 (15.8%) men and 129 (7.3%) 
women) and 2107 (90.7%) participants were censored (460 
(84.2%) men and 1647 (92.7%) women) (ie, did not present 
any event). Deceased men were older (mean difference (95% CI) 
3.8 (2.4 to 5.1) years old; p<0.001), presented lower allome-
tric and relative muscle power values at baseline (‒8.8 (‒14.7 
to ‒3.0) W/m2, p=0.003 and ‒0.26 (‒0.45 to ‒0.08) W/kg1, 
p=0.006, respectively) and were less likely to have hyperten-
sion (p=0.004) and more likely to be smokers (p=0.030) when 
compared with surviving men (table 2). No differences were 
noted between deceased and surviving men regarding BMI, waist 
circumference, body fat percentage, fat index, STS performance 
and walking and sitting times (all p>0.05). Among women, 
those who died were older (4.5 (3.6 to 5.4) years old; p<0.001), 
exhibited lower values of STS performance (‒1.0 (‒1.7 to ‒0.4) 
reps; p=0.003), allometric power (‒8.1 (‒11.8 to ‒4.5) W/m2; 
p<0.001) and relative power (‒0.28 (‒0.41 to ‒0.14) W/kg1; 
p<0.001) and were more likely to have hypertension (p=0.026) 
than the surviving women (table 2). No differences were found 
between deceased and surviving women in terms of BMI, waist 
circumference, body fat percentage, fat index, walking and 
sitting times and smoking status (all p>0.05).
Figure 1 Directed acyclic graph showing the relationship between the exposure (‘Fat but powerful’ phenotype) and outcome (all- cause mortality) 
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Comparisons among groups of power and adiposity regarding 
all-cause mortality
Survival plots showing the cumulative probability of survival 
among the different groups of allometric muscle power and 
adiposity are displayed in figure 2.
Among the groups of allometric muscle power and BMI, HRs 
of all- cause mortality were significantly reduced in the F+P (HR 
(95% CI) 0.55 (0.31 to 0.98); p=0.044) and L+P (HR (95% CI) 
0.57 (0.33 to 0.98); p=0.043) groups when compared with 
the F+W group. No significant differences existed between the 
L+W participants (HR (95% CI) 0.80 (0.45 to 1.44); p=0.462) 
and the reference group (figure 3A).
Similarly, when allometric power and waist circumference 
were regarded, all- cause mortality risk was significantly reduced 
Table 2 Comparison between deceased and surviving older men and women
Men Women
Deceased Surviving Deceased Surviving
Mean±SD Mean±SD Mean±SD Mean
Age (years) 75.1±6.1 71.3±4.9* 76.1±5.7 71.6±5.0*
BMI (kg·m−2) 27.9±3.9 28.3±3.3 29.6±4.0 29.5±4.3
Waist circumference (cm) 99.9±10.8 98.9±9.5 94.1±11.8 93.1±12.3
Body fat (%) 29.2±5.2 28.9±5.1 39.6±5.8 39.7±5.2
Fat index (kg·m−2) 8.3±2.5 8.3±2.2 11.9±3.0 11.9±3.1
STS performance (reps) 14.4±4.0 15.2±3.3 13.1±3.8 14.1±3.2
Allometric power (W·m−2) 92.5±28.9 101.4±24.8 73.3±22.2 81.4±20.3
Relative power (W·kg−1) 3.3±0.9 3.6±0.8* 2.5±0.8 2.8±0.7
Hypertension (yes, n(%)) 33(38.4) 285(55.2)* 77(59.7) 907(49.5)*
Smoking (yes, n(%)) 13(15.1) 40(7.8)* 3(2.3) 31(1.7)
Walking <1 hour·day−1 (yes, n(%)) 23(26.7) 147(28.5) 53(41.1) 641(35.0)
Sitting ≥5 hour·day−1 (yes, n(%)) 20(23.3) 90(17.4) 23(17.8) 260(14.2)
*Statistically significant differences between deceased and surviving participants (p<0.01).
BMI, body mass index; STS, sit- to- stand.
Figure 2 Survival probability for the different groups of adiposity and allometric power throughout the 9 year follow- up. aAdjusted for age, sex, 
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in F+P (HR (95% CI) 0.63 (0.40 to 0.99); p=0.049) and L+P 
(HR (95% CI) 0.58 (0.36 to 0.94); p=0.025) participants 
compared with the reference group, while no significant reduc-
tion was found in the L+W group (HR (95% CI) 0.84 (0.48 to 
1.46); p=0.539) (figure 3B).
In terms of allometric power and body fat percentage, HRs 
were again significantly lower in the L+P group (HR (95% CI) 
0.53 (0.30 to 0.91); p=0.021), while a trend for a reduction 
was noted in the F+P participants (HR (95% CI) 0.57 (0.31 to 
1.02); p=0.060) in comparison to the F+W group. All- cause 
mortality risk was not significantly different in the L+W group 
(HR (95% CI) 0.72 (0.40 to 1.31); p=0.721) when compared 
with the reference group (figure 3C).
Among the groups of allometric power and fat index, the L+P 
group was the only group showing a significantly reduced all- 
cause mortality risk when compared with the F+W participants 
(HR (95% CI) 0.50 (0.25 to 0.99); p=0.049), and, thus, nonsig-
nificant reductions were noted in the F+P (HR (95% CI) 0.55 
(0.25 to 1.20); p=0.133) and L+W (HR (95% CI) 0.72 (0.35 to 
1.49); p=0.370) groups (figure 3D).
Influence of relative muscle power on all-cause mortality
Finally, when introduced as a continuous variable, higher rela-
tive muscle power significantly reduced mortality risk among the 
older adults independently of age, sex, hypertension, smoking 
and walking and sitting times (HR (95% CI) 0.78 (0.63 to 0.97); 
p=0.025). In addition, a significantly reduced HR of all- cause 
mortality was noted in the participants with normal relative 
muscle power (HR (95% CI) 0.60 (0.42 to 0.86); p=0.006) and 
high relative muscle power (HR (95% CI) 0.52 (0.32 to 0.86); 
p=0.011) when compared with those with low relative muscle 
power (figure 4).
DISCUSSION
The main findings of the present investigation were that the 
L+P older adults presented a significantly diminished all- cause 
mortality risk, while the F+P participants showed a signifi-
cantly reduced all- cause mortality risk only when BMI and waist 
circumference were considered (all independently of age, sex, 
hypertension, smoking status and walking and sitting times). 
Moreover, normal and high levels of relative muscle power, 
which require appropriate combinations of allometric power 
and BMI, independently decreased all- cause mortality in older 
people.
Muscle power and all-cause mortality
Traditionally, cardiorespiratory fitness has been considered 
the cornerstone of physical fitness.3 In recent decades, muscle 
strength and resistance training have gained increased attention 
Figure 3 Hazard ratios with 95% CIs of all- cause mortality among the different groups of allometric muscle power (powerful, blue circles, vs weak, 
red triangles) and adiposity (fat vs lean) according to BMI (A), waist circumference (B), body fat percentage (C) and fat index (D). BMI, body mass 
index. Bold values denote statistically significant differences (p<0.05) compared with the reference category (fat and weak). aAdjusted for age, sex, 
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as numerous studies have reported their overall benefits,20 21 
especially in older and clinical populations.22–25 For example, 
handgrip strength was demonstrated to be the third strongest 
modifiable risk factor for mortality when considered together 
with other behavioural, metabolic, socioeconomic and psycho-
social factors, household and ambient pollution.26 Notably, 
it was found out that muscle power is a stronger predictor of 
functional ability in older people than muscle strength, muscle 
mass and aerobic capacity.6 27 28 Specifically, power values 
obtained from the STS muscle power test have been reported 
to be more clinically relevant than handgrip strength and sarco-
penia in older people.15 29 30 In addition, Metter et al7 demon-
strated a significant association between low upper limb absolute 
muscle power and mortality in middle- aged men after a 25- year 
follow- up, independently of muscle mass, strength and physical 
activity. However, due to (1) absolute muscle power is positively 
correlated with height and (ii) height progressively decreases 
across generations, the association between absolute muscle 
power and mortality may be—at least—partially explained by 
this aspect. Thus, we assessed allometric power (absolute power 
normalised to height squared) and confirmed the independent 
association of low muscle power with all- cause mortality in older 
men and women.
The ‘fat but fit/powerful’ paradox
Of note, in the current study being powerful seemed to be an 
independent requisite to live longer, while being lean was not. 
Previous studies have reported that body composition and 
physical fitness do not have equivalent influence on all- cause 
mortality risk. Ortega et al3 reported that being fit according 
to cardiorespiratory capacity decreased mortality risk in both 
men and women independently of the level of BMI, body fat 
percentage or waist circumference, while unfit individuals 
presented an increased mortality risk whether they were obese or 
not. Muscle function was also responsible for a greater propor-
tion of deaths than abdominal obesity, hypertension, diabetes 
and high blood cholesterol.26 The superiority of physical fitness 
over body composition regarding all- cause mortality risk was 
especially evident among older adults. Sui et al5 found that all- 
cause mortality risk was strongly modulated by cardiorespiratory 
fitness, while being obese or nonobese had no apparent effect 
on either fit or unfit older individuals. Similarly, we noted that 
the lean participants only presented a significantly decreased 
mortality risk when they were powerful as well, while all- cause 
mortality risk was generally significantly reduced in the powerful 
participants whether they were obese or not. This aspect should 
be considered when studying the so- called obesity paradox in 
older adults,31 since muscle function may act as a confounding 
factor and contribute, at least partially, to the observations about 
the benefits of having a greater BMI on the severity of certain 
cardiovascular conditions.32
However, in contrast to other adiposity measures, the obese 
group according to fat index values did not benefit significantly 
from being powerful. Of note, BMI and waist circumference are 
used as proxies of fat mass or obesity, while body fat percentage 
also depends on other tissues (eg, body fat percentage is reduced 
by increasing muscle mass). Therefore, fat index is the adiposity 
marker that better and more independently reflects the amount 
of fat mass an individual has, which may explain the observed 
discrepancies among the adiposity measures. The harmful effects 
of obesity have been directly related to an excessive accumula-
tion of fat mass, leading to the infiltration of adipocytes within 
other tissues, increased systemic low- grade inflammation, loss of 
function and augmented mortality.33–35 Thus, an excessive accu-
mulation of fat mass (ie, high fat index) would counteract the 
benefits of having adequate power levels. Nonetheless, all- cause 
mortality was lower (although non- significantly) in the F+P 
than in the L+W participants; thus, whether the F+P partici-
pants according to fat index may still experience clinical bene-
fits deserves to be further investigated. Furthermore, among the 
adiposity indexes, the highest survival benefit when compared 
with the F+W group was observed in L+P individuals according 
to fat index.
Relationship between relative muscle power and all-cause 
mortality
On the other hand, we also assessed the influence of relative 
muscle power on all- cause mortality among older people. Actu-
ally, relative muscle power combines a measure of physical fitness 
(allometric power) and a measure of adiposity (BMI) and is a 
more functionally relevant outcome compared with absolute or 
allometric muscle power.36 37 In this sense, we observed normal 
and high levels of relative muscle power to protect against 9- year 
Figure 4 Survival probability (A) and hazard ratios with 95% CIs of all- cause mortality (B) for the different groups of relative muscle power 
throughout the 9 year follow- up. Bold values denote statistically significant differences (p<0.05) compared with the reference category (low relative 
power). aAdjusted for age, sex, hypertension, smoking and walking and sitting times. bDeaths within the first 24 months were excluded to minimise 
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all- cause mortality independently of age, sex, hypertension, 
smoking, physical activity and sedentary time. Particularly, the 
survival benefits of relative muscle power seemed to plateau, 
and the protection conferred by high relative muscle power was 
relatively similar to that observed in the individuals with normal 
levels. The latter suggests that the relationship between relative 
muscle power and mortality is curvilinear. These findings help 
explain why the L+P individuals generally did not exhibit a 
greater survival benefit than the fat and powerful participants. 
Relative muscle power increased progressively across the F+W, 
L+W, F+P and L+P groups (weighted mean±SD = 1.75±0.40 
W/kg, 2.16±0.46 W/kg, 2.90±0.58 W/kg and 3.25±0.61 W/
kg, respectively). Therefore, above a certain level of relative 
muscle power, no further survival benefits were noted. This 
curvilinear relationship has also been reported for the relation-
ship between relative muscle power and physical performance in 
older adults.36 38
Limitations
Among the main limitations of the study, there was a relatively 
moderate- to- high type II error probability for the comparisons 
between the F+W and L+W groups (ie, β>0.2). In this sense, 
future analyses comprising longer follow- up periods and larger 
number of events may denote a significant benefit derived from 
being L+W compared with F+W. However, this issue does not 
limit the conclusions reported regarding the survival benefits of 
being powerful regardless of obesity. It should be noted that the 
present investigation focused on independently living and non- 
institutionalised older adults, so our results may not apply to 
other older populations. On the contrary, the representativeness 
of our sample makes our results applicable to the general popu-
lation of noninstitutionalised Spanish older adults. In addition, a 
comprehensive assessment and recording of medical conditions 
and previous smoking was not performed, which could have 
improved our cox regression models. In this line, the consider-
ation of other potential confounding variables may be of rele-
vance for future studies. However, we did consider the main 
medical conditions and risk factors that have been related to all- 
cause mortality (hypertension, smoking, physical inactivity and 
obesity).16 On the other hand, interventions assessing the impact 
of improving or worsening muscle power on all- cause mortality 
need to be conducted to establish a causal relationship. There is 
evidence showing that participation in strength training provides 
survival benefits,23 but whether this aspect is related to induced 
muscle power adaptations remains to be investigated. Finally, 
the procedure used in the present study to assess muscle power 
augments the applicability of our results, given that the STS 
muscle power test8 9 39 is a valid, feasible and rapid test that can 
be performed in almost any global context, as long as a chair and 
a stopwatch are available. Further studies should be conducted 
to assess the influence of the ‘fat but fit (powerful)’ paradox on 
the incidence of specific medical conditions and hospitalisation.
CONCLUSIONS
Older people with adequate levels of muscle power exhibited 
a reduction in 9- year all- cause mortality whether they were 
obese or not (according to BMI, waist circumference or body 
fat percentage), while being lean was a survival factor only when 
accompanied by adequate levels of muscle power. However, 
when fat index was regarded, reduced all- cause mortality risk 
was only observed in L+P older adults, and so the survival bene-
fits derived from being powerful were counteracted by the obese 
condition. Therefore, the ‘fat but fit/powerful’ paradox should 
be revisited using fat index as the adiposity marker. Finally, low 
relative muscle power assessed with the STS muscle power test 
was an independent risk factor for 9- year all- cause mortality in 
a representative sample of noninstitutionalised Spanish older 
people.
Key messages
What are the findings?
 ► Older men and women with adequate levels of muscle 
power showed a 9- year survival benefit compared with their 
counterparts with low levels of muscle power, regardless 
of body mass index, waist circumference and body fat 
percentage levels.
 ► Obesity according to fat index (ie, body fat normalised to 
height squared) mitigated the survival benefits provided by 
adequate levels of muscle power in older adults.
 ► The ‘fat but fit/powerful’ paradox was confirmed when 
adiposity was assessed by BMI, waist circumference and body 
fat percentage, but not by fat index.
 ► Low relative muscle power (ie, power normalised to body 
mass) was an independent predictor of 9- year all- cause 
mortality among older people.
How might it impact on clinical practice in the future?
 ► If possible, the assessment of fat index should be preferred 
over other adiposity markers since it is more appropriate for 
quantifying the amount of body fat and was the only obesity 
marker that mitigated the survival benefits of muscle power.
 ► Nevertheless, in the fatness and fitness binomial, the 
greatest importance should be granted to the physical fitness 
component in terms of preventing mortality among older 
people.
 ► The assessment of low relative muscle power should be 
strongly encouraged in daily clinical practice given the 
previous evidence showing its detrimental consequences on 
physical performance and the novel evidence demonstrating 
its harmful effect on all- cause mortality among older people.
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